Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer.
Fossella FV, Lee JS, Murphy WK, Lippman SM, Calayag M, Pang A, Chasen M, Shin DM, Glisson B, Benner S, et al.
Fossella FV, et al. Among authors: lee js.
J Clin Oncol. 1994 Jun;12(6):1238-44. doi: 10.1200/JCO.1994.12.6.1238.
J Clin Oncol. 1994.
PMID: 7911160
Clinical Trial.